Literature DB >> 29028704

Aspirin for Sepsis Prophylaxis: An Ounce of Prevention?

Jonathan D Casey1, Matthew W Semler, Julie A Bastarache.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29028704      PMCID： PMC5658041          DOI： 10.1097/CCM.0000000000002669

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  14 in total

1.  The search for effective therapy for sepsis: back to the drawing board?

Authors:  Derek C Angus
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods.

Authors:  Thérèse A Stukel; Elliott S Fisher; David E Wennberg; David A Alter; Daniel J Gottlieb; Marian J Vermeulen
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

4.  Who cares about preventing acute respiratory distress syndrome?

Authors:  Gordon D Rubenfeld
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

5.  Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching.

Authors:  James Trauer; Stephen Muhi; Emma S McBryde; Shmeylan A Al Harbi; Yaseen M Arabi; Andrew J Boyle; Rodrigo Cartin-Ceba; Wei Chen; Yung-Tai Chen; Marco Falcone; Ognjen Gajic; Jack Godsell; Michelle Ng Gong; Daryl Kor; Wolfgang Lösche; Daniel F McAuley; Hollis R O'Neal; Michael Osthoff; Gordon P Otto; Maik Sossdorf; Min-Juei Tsai; Juan C Valerio-Rojas; Tom van der Poll; Francesco Violi; Lorraine Ware; Andreas F Widmer; Maryse A Wiewel; Johannes Winning; Damon P Eisen
Journal:  Crit Care Med       Date:  2017-11       Impact factor: 7.598

6.  Hospital deaths in patients with sepsis from 2 independent cohorts.

Authors:  Vincent Liu; Gabriel J Escobar; John D Greene; Jay Soule; Alan Whippy; Derek C Angus; Theodore J Iwashyna
Journal:  JAMA       Date:  2014-07-02       Impact factor: 56.272

7.  Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial.

Authors:  Daryl J Kor; Rickey E Carter; Pauline K Park; Emir Festic; Valerie M Banner-Goodspeed; Richard Hinds; Daniel Talmor; Ognjen Gajic; Lorraine B Ware; Michelle Ng Gong
Journal:  JAMA       Date:  2016-06-14       Impact factor: 56.272

8.  15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.

Authors:  Driss El Kebir; Levente József; Wanling Pan; Lili Wang; Nicos A Petasis; Charles N Serhan; János G Filep
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

Review 9.  Strategies to improve drug development for sepsis.

Authors:  Mitchell P Fink; H Shaw Warren
Journal:  Nat Rev Drug Discov       Date:  2014-09-05       Impact factor: 84.694

10.  AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol.

Authors:  Damon P Eisen; Elizabeth M Moore; Karin Leder; Jessica Lockery; Emma S McBryde; John J McNeil; David Pilcher; Rory Wolfe; Robyn L Woods
Journal:  BMJ Open       Date:  2017-01-20       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.